Excessive wandering in @entity1 in @entity303 is associated with a severe care burden. However, the quantification of excessive wandering has not been described, and its cause and treatment have not been evaluated with objective measurements to date. The purpose of this study was to evaluate pharmacological treatments and non-pharmacological interventions to reduce excessive wandering in an early-onset @entity195 @entity1 with objective indicators. Wandering was quantified using an integrated circuit monitoring system that measured the distance moved and the location of the @entity1 . Monitoring was conducted in the @entity303 ward of a general hospital in 2012. Sleep quality was measured by non-wear actigraphy. The study was approved by the ethics committees of the Osaka University School of Allied Health Science, and of the study hospital. The case involved a 62-year-old @entity1 diagnosed with early-onset @entity195 and hospitalized in 2012 because of @entity146 and @entity2146 ; her Mini-Mental State Examination score was 5/30 and her Clinical @entity303 Rating score was 3. When @entity1037 (2.5   mg) was prescribed, she developed @entity22 , and her wandering movements increased from 10 to 20   km/day. On some days, it exceeded 30   km/day, and she walked most of the night. She did not experience @entity353 or physical exhaustion, but she sustained a @entity130 in her left sole. @entity1037 was increased to 7.5   mg, but these problems persisted. Nursing staff discovered triggers for wandering and @entity22 , including high sensitivity to odour and noise in the living room or her room. When the environment was changed to meet her needs, the distance moved per day decreased to <15   km and the @entity25 disappeared. This case demonstrated the difficulty in assessing the degree of ambulation and @entity25 . Objective indicators are essential in evaluating the effectiveness of pharmacological and non-pharmacological interventions.

Caring for early-onset XXXX with excessive wandering of over 30 kilometres per day: a case report.

@entity1 :: ('9606', 'Species') :: ['woman', 'patient', 'people'] @entity353 :: ('MESH:D015431', 'Disease') :: ['weight loss'] @entity146 :: ('MESH:D001523', 'Disease') :: ['irritability'] @entity303 :: ('MESH:D003704', 'Disease') :: ['Dementia', 'dementia'] @entity2146 :: ('MESH:D011595', 'Disease') :: ['agitation'] @entity195 :: ('MESH:D000544', 'Disease') :: ['Alzheimer disease'] @entity1037 :: ('MESH:C076029', 'Chemical') :: ['Olanzapine', 'olanzapine'] @entity25 :: ('MESH:D012893', 'Disease') :: ['sleep disorder', 'sleep disturbances'] @entity130 :: ('MESH:D014947', 'Disease') :: ['minor injury'] @entity22 :: ('MESH:D007319', 'Disease') :: ['insomnia']
@entity303 :: (MESH:D003704,Disease) :: ['dementia']
